TCT 2008 schedule

Here is the page we will use to coordinate the TV events at TCT 2008

Contact information:

---

There are press conferences about the late breaking trials on Tuesday, Wednesday and Thursday. These are scheduled to begin aroun 12:15 or 12:30. Once these are completed, we will escort the presenters/moderators to the TCT TV studio (Room 305) for an interview/discussion session w/ Mike.

We are attempting to set up additional segmented interviews throughout the week with other TCT faculty.

Contact information: Josh Hartman jhartman@crf.org (212) 851-9350 or at the booth 202-249-4505.

---

Click on Date for Detailed Schedule

Saturday October 11, 2008

Sunday October 12, 2008

Monday October 13, 2008

Tuesday October 14, 2008

Wednesday October 15, 2008

Thursday October 16, 2008

---

Saturday October 11, 2008

2:00 PM

2:00 - 5:00 PM

• Event: ALERT AMI Investigator Meeting
• Location: Room #3 at the Renaissance Hotel

4:00 PM

4:00 – 5:45 PM

• Event: Interventional Scientific Council Meeting and Workgroup Breakout Session
• Location: Heart House

Return to top

Sunday October 12, 2008

12:40 PM

12:40 -1:55 PM

• Topic: Interventional Strategies and Adjunct Pharmacology in ACS and AMI, Part I: Unstable Angina and NSTEMI. Session II Chest Pain Evaluation and Management Strategies
• Room: 147 B
• Role: Moderator

1:40 - 1:55 PM

• Topic: Interventional Strategies and Adjunct Pharmacology in ACS and AMI, Part I: Unstable Angina and NSTEMI. Session II Chest Pain Evaluation and Management Strategies
• Details: Moderated Roundtable Discussion and Audience Q&A
• Room: 147 B
• Role: Panel Moderator

5:12 PM

5:12 – 5:22 PM

• Topic: Interventional Strategies and Adjunct Pharmacology in ACS and AMI, Part I: Unstable Angina and NSTEMI. ACS Session IV: Antiplatelet and Antithrombin Decisions in NSTE-ACS: Data-driven Debates
• Details: Thienopyridine Decisions: Clopidogrel vs. Prasugrel in NSTE-ACS? Prasugrel for Most: Preserve the Myocardium, and Keep Stents from Thrombosing!
• Room: 147 B
• Role: Lecturer

5:42 PM

5:42 – 5:52 PM

• Topic: Interventional Strategies and Adjunct Pharmacology in ACS and AMI, Part I: Unstable Angina and NSTEMI. ACS Session IV: Antiplatelet and Antithrombin Decisions in NSTE-ACS: Data-driven Debates
• Details: Thienopyridine Decisions: Clopidogrel vs. Prasugrel in NSTE-ACS? Roundtable Discussion, and Questions from the Erudite Panel and Audience
• Room: 147 B
• Role: Discussant

8:30 PM

• Dinner

Return to top

Monday October 13, 2008

9:00 AM

9:00 - 10:00 AM

• eSCAI meeting

10:20 AM

10:20-10:30 AM

• Topic: The DES Summit: Dual Anti-Platelet Use Considerations
• Details: Other Important Antiplatelet Agents. Prasugrel – A Potent Newcomber: Optimizing Use to Reduce Stent Thrombosis without Increasing Bleeding!
• Room: Ballroom C
• Role: Lecturer

10:30 AM

10:30 – 10:42 AM

• Topic: The DES Summit: Dual Anti-Platelet Use Considerations
• Details: Other Important Anti-Platelet Agents. Discussion with Audience Q&A
• Room: Ballroom C
• Role: Discussant

3:15 PM

3:15 – 5:30 PM

TCT-TV Smaller Interviews

3:15 PM

• Interviewee: G. Dangas
• Confirmed (Y/N): Y
• Topic: Interruption of Dual Antiplatelet Therapy
• Slides (Y/N):

3:30 PM

• Interviewee: M. Farkouh
• Confirmed (Y/N): Y
• Topic: Update on the FREEDOM trial
• Slides (Y/N):

3:45 PM

• Interviewee: N. Pijls
• Confirmed (Y/N): Y
• Topic: The Treatment of MVD
• Slides (Y/N):

4:00 PM

• Interviewee: R. Schwartz
• Confirmed (Y/N): Y
• Topic: The Integration of advanced imaging into interventional practice – the future.
• Slides (Y/N):

4:15 PM

• Interviewee: Fred Feit
• Confirmed (Y/N): Y
• Topic: Future of Medical Communications
• Slides (Y/N): N

4:30 PM

• Interviewee: S-W Park
• Confirmed (Y/N): Y
• Topic: Results of DECREASE-Registry
• Slides (Y/N): Y

5:00 PM

• Interviewee: Z. Hijazi
• Confirmed (Y/N): Y
• Topic: Structural heart disease (what’s new, what’s in the pipeline)
• Slides (Y/N):

5:15 PM

• Interviewee: M. Krucoff
• Confirmed (Y/N): Y
• Topic: Challenges Facing New DES: Can We Tell "Newer" From "Better"?
• Slides (Y/N):

5:30 PM

5:30 – 6:30 PM

• Interviewee: Dean Kereiakes
• Confirmed (Y/N): Y
• Topic: A topic dealing with a nuclear substudy of the COURAGE trial
• Slides (Y/N): Y

6:30 PM

Return to top

Tuesday October 14, 2008

8:30 AM

8:30 – 9:30 AM

• Event: Breakfast meeting
• Location: Grand Hyatt

10:30 AM

10:30 – 11:00 AM

• Topic: Main Arena I Plenary Sessions 3: PCI Controversies I
• Details: The Appropriate Utilization of Antithrombotic and Antiplatelet Therapies
• Room: Ballroom – Third Floor
• Role: Discussant

11:00 AM

11:00 AM - 1:00 PM

• Meeting

1:06 PM

1:06 - 1:11 PM

• Topic: Controversies in Adjunct Pharmacology: Agenda
• Details: Upstream Drug Initiation in ACS - Impact on Clinical and Angiographic Outcomes
• Room: 201
• Role: Lecturer

1:11 PM

1:11 - 1:14 PM

• Topic: Controversies in Adjunct Pharmacology: Agenda
  
• Details: Audience Q&A
• Room: 201
• Role: Case Discussant

1:22 PM

• 1:22 - 1:42 PM
• Topic: Controversies in Adjunct Pharmacology: Agenda
• Details: Discussion with Audience Q&A
• Room: 201
• Role: Panel Discussant

2:00 PM

2:00-3:00

• Topic: TCT-TV
• Details: Interviews/Discussion w/ late breaking trial presenters for Tuesday
• Room: 305
• Confirmed Participants: C. M. Gibson, M. Leon, C. Smith, K. Beatt, D. Taggart

3:05 PM

3:05 - 3:30 PM

• Topic: Exploring the Guidelines: Evidence Based Medicine Review and Debates

Hot Topic 2: ACS Controversies: Adjunct Pharmacology and Conservative vs Invasive Approach

• Details: Roundtable Discussion with Audience Q&A: Are the guidelines consistent with clinical practice and the latest clinical trial results?
• Room: 209 ABC
• Role: Disucussant

3:30 PM

3:30 - 4:30 PM

• Event: Meet with Jay Zimmerman and Dr. Sardella
• Location: Outside room 209 ABC

5:30 PM

5:30 - 6:30 PM

TCT-TV Smaller Interviews

5:30 PM

• Interviewee: Sid Smith
• Confirmed (Y/N): Y
• Topic:
• Slides (Y/N):

5:45 PM

• Interviewee: Gary Mintz
• Confirmed (Y/N): Y
• Topic: An update in the state of the art in ultrasound and its clinical application in practice
• Slides (Y/N): N

6:00 PM

• Interviewee: Alice Jacobs
• Confirmed (Y/N): Y
• Topic: American Heart Association’s STEMI initiative “Mission: Lifeline”
• Slides (Y/N):

6:15 PM

• Interviewee: Marty Leon
• Confirmed (Y/N): Y
• Topic:
• Slides (Y/N):

7:00 PM

7:00 - 10:00 PM

• Event: TCT Live Symposium and interview JJP
• Location: Marriott at Metro Center

Return to top

Wednesday October 15, 2008

8:40 AM

8:40 - 8:55 AM

• Topic: Coronary Theater - II: Focus on Interventional Pharmacology
• Details: Upstream and Downstream Use of Glycoprotein IIb/IIIa Inhibitors: Integrating the Latest Clinical Trial Results
• Room: Coronary Theater, Lower Level
• Role: Lecturer

9:00 AM

9:00 - 10:30 AM

• Event: Late Breaking Trials Registries and First Report Investigations Press Conference
• Room: 159A
• Role: Moderator

12:27 PM

12:27 - 12:30 PM

• Topic: Main Arena II: Plenary Session 14: "First Report" Randomized Trials & Registries II
• Details: Critique and Clinical Perspectives
• Room: Ballroom- Third Level
• Role: Critical Commentary

12:45 PM

12:45 - 1:30 PM

• Topic: TCT-TV
• Details: Interviews/Discussion w/ late breaking trial presenters for Wednesday
• Room: 305
• Confirmed Participants: C. M. Gibson, K. Koch, G. Stone

2:30 PM

2:30 - 5:30 PM

TCT-TV Smaller Interviews

2:30 PM

• Interviewee: Harvey White
• Confirmed (Y/N): Y
• Topic: ACUITY study
• Slides (Y/N):

2:45 PM

• Interviewee: Jim Hermiller
• Confirmed (Y/N): Y
• Topic: Percutaneous approach to functional MR using evalve
• Slides (Y/N):

3:00 PM

• Interviewee: Matthew Price
• Confirmed (Y/N): Y
• Topic: The clinical implications of clopidogrel nonresponsives and the design and rationale of the GRAVITAS trial
• Slides (Y/N): Y

3:15 PM

• Interviewee: Jeff Popma
• Confirmed (Y/N): Y
• Topic: Corevalve Percutaneous Aortic Valve
• Slides (Y/N):

3:30 PM

• Interviewee: Mike Jaff
• Confirmed (Y/N): Y
• Topic: The three major clinical challenges facing vascular specialists
• Slides (Y/N):

3:45 PM

• Interviewee: Cindy Grines
• Confirmed (Y/N): Y
• Topic: Late Breaking Trials at TCT
• Slides (Y/N): N

4:00 PM

• Interviewee: David Holmes, Jr.
• Confirmed (Y/N): Y
• Topic: Angel Med ALERT AMI trial
• Slides (Y/N):

4:15 PM

• Interviewee:
• Confirmed (Y/N):
• Topic:
• Slides (Y/N):

4:45 PM

• Interviewee: David Cohen
• Confirmed (Y/N): Y
• Topic: 1. Update on the economics of drug eluting stents: Insights from the Medicare database, 2. Troponin and PCI outcomes--

not just for ACS patients?, 3. Optimal duration of dual antiplatelet therapy after DES

• Slides (Y/N):

5:00 PM

• Interviewee: Bonnie Weiner
• Confirmed (Y/N): Y
• Topic:
• Slides (Y/N):

5:15 PM

• Interviewee: Paul Teirstein
• Confirmed (Y/N):
• Topic:
• Slides (Y/N):

6:30 PM

• Meeting

Return to top

Thursday October 16, 2008

9:50 AM

9:50 - 11:05 AM

• Topic: Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Antithrombins, Xa Inhibitors and Emerging Agents

Session III: Current Antithrombin Choices for PCI (elective, NSTEMI and STEMI)

• Room: 145 AB
• Role: Moderator

10:50 - 11:05 AM

• Topic: Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Antithrombins, Xa Inhibitors and Emerging Agents

Session III: Current Antithrombin Choices for PCI (elective, NSTEMI and STEMI)

• Details: Moderated Roundtable Discussion with Audience Q&A
• Room: 145 AB
• Role: Panel Moderator

12:30 PM

12:30 - 1:30 PM

• Topic: TCT-TV
• Details: Interviews/Discussion w/ late breaking trial presenters for Thursday
• Room: 305
• Confirmed Participants: C. M. Gibson, D. Hildick-Smith, J. Lassen, R. Byrne

2:30 PM

2:30 - 5:00 PM

TCT-TV Smaller Interviews

2:30 PM

• Interviewee: Roxana Mehran
• Confirmed (Y/N): Y
• Topic: HORIZONS AMI
• Slides (Y/N):

3:00 PM

• Interviewee: Gregg Stone
• Confirmed (Y/N): Y
• Topic: Drug-eluting stents in AMI – the HORIZONS Trial
• Slides (Y/N):

3:15 PM

• Interviewee: Renu Virmani
• Confirmed (Y/N): Y
• Topic: Drug Eluting Stents (DES) and Acute Myocardial Infarction or DES and Atherosclerosis
• Slides (Y/N):

3:30 PM

• Interviewee: David Antoniucci
• Confirmed (Y/N): Y
• Topic: Dual non-responsiveness to aspirin and clopidopgrel and outcome (RECLOSE trial). Alternatively PCI for CTO, or thrombectomy in AMI
• Slides (Y/N):

4:00 PM

• Interviewee: Ajay Kirtane
• Confirmed (Y/N): Y
• Topic: Re-cap of TCT 2008 (positives, negatives etc)
• Slides (Y/N):N

4:15 PM

• Interviewee: Patrick Serruys
• Confirmed (Y/N): Y
• Topic: SYNTAX
• Slides (Y/N):

4:30 PM

• Interviewee: Ted Feldman
• Confirmed (Y/N): Y
• Topic: Current status of percutaneous mitral valve therapy or PCI for left main & 3 vessel CAD
• Slides (Y/N):

4:45 PM

• Interviewee: Carlo Briguori
• Confirmed (Y/N): Y
• Topic: Peri-procedural complication following stent implantation in diabetic patients: focus on bleeding
• Slides (Y/N): Y

6:30 PM

Return to top

---

Mike:

Here are two lists. List 1 is the a list of those people who I think would be interesting interviewees. List 2 are moderators/presenters of late breaking trials.

List 1: Bill Gray, Cindy Grines, Jim Hermiller, Jeff Popma, Matt Price, Deepak Bhatt, Ziyad Hijazi, David Holmes, Alice Jacobs, Mike Jaff, Mark Reisman, Dave Kandzari, Barry Katzan, Ajay Kirtane, David Cohen, Mitch Krucoff, Marty Leon, Rob Schwartz, David Cox, George Dangas, Sid Smith, Bob Sommer, Steve Steinhubl, Gregg Stone, Paul Teirstein, Mike Farkouh, Roxana Mehran, Gary Mintz, Mark Turco, Renu Virmani, Fred Feit, Ted Feldman, Pedro Moreno, Bonnie Weiner, Mat Williams, Jay Yadav and Shelly Goldberg, Alex Abizaid,

List 2: Gregg Stone, Marty Leon, Friedrich W. Mohr, Patrick W. Serruys, Julinda Mehilli, Nico H.J. Pijls, Eberhard Grube, Dean Kereiakes, Giulio Guagliumi, S-W Park, Emmanuouil Brilakis, Roxana mehran, C-H Lee, Karel Koch, David Antoniucci, Carlo Briguori, Bernardo Cortese, Michel Le May, Drancesco Saia

Can you go through these lists and identify which of these people you want to schedule interviews/discussions with? Once you do that, I will have their time booked in their official schedule with TCT. Obviously if you have additions, please let me know.